Pre-clinical validation study of a miniaturized electrochemical immunoassay based on square wave voltammetry for early detection of carcinoembryonic antigen in human serum

Clinica Chimica Acta

Volumn 444, Issue , 2015, Pages 199-205

  Martínez Mancera, Flavio Dolores ^a   García López, Patricia ^b   Hernández López, José Luis ^a  

^a CENTRO DE INVESTIGACIÓN Y DESARROLLO TECNOLÓGICO EN ELECTROQUÍMICA   (Mexico)

^b INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

Biostatistical analysis; Carcinoembryonic antigen; ELISA test system; Magnetic beads; Miniaturization; Square wave voltammetry

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; LEAD; TUMOR MARKER;

ACCURACY; ANTIGEN DETECTION; ARTICLE; BLOOD ANALYSIS; CALIBRATION; CONTROLLED STUDY; ELECTROCHEMICAL IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; POTENTIOMETRY; PRIORITY JOURNAL; PRODUCT RECOVERY; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SCANNING ELECTRON MICROSCOPY; SENSITIVITY AND SPECIFICITY; SQUARE WAVE VOLTAMMETRY; TRANSMISSION ELECTRON MICROSCOPY; VALIDATION STUDY; BIOSTATISTICS; BLOOD; DEVICES; EARLY CANCER DIAGNOSIS; ELECTROCHEMICAL ANALYSIS; PARTICLE SIZE; SURFACE PROPERTY;

BIOMARKERS, TUMOR; BIOSTATISTICS; CARCINOEMBRYONIC ANTIGEN; EARLY DETECTION OF CANCER; ELECTROCHEMICAL TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; PARTICLE SIZE; SURFACE PROPERTIES;

EID: 84924083209     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2015.02.017     Document Type: Article

References (56)

1. D'Orazio P. Biosensors in clinical chemistry. Clin Chim Acta 2011, 412:1749-1761.
2. Szturmowicz M., Tomkowski W., Fijalkowska A., Sakowicz A., Filipecki S. 1268 Is an increased carcinoembryonic antigen (CEA) concentration in pericardial fluid an indication of malignant pericarditis?. Eur J Cancer 1995, 31:S264.
3. Villena V., Lopez-Encuentra A., Echave-Sustaeta J., Martin-Escribano P., Ortuño-de-Solo B., Estenoz-Alfaro J. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9. Cancer 1996, 78:736-740.
4. Behera D., Raghavendra V., Khanduja K.L. Carcinoembryonic antigen and sialic acid levels (total and lipid bound) in patients with lung cancer. Lung Cancer 1997, 18:168.
5. Wang W.S., Lin J.K., Lin T.C., Chiou T.J., Liu J.H., Yen C.C., et al. EIA versus RIA in detecting carcinoembryonic antigen level of patients with metastatic colorectal cancer. Hepato-Gastroenterology 2004, 51:136-141.
6. Liew M., Groll M.C., Thompson J.E., Call S.L., Moser J.E., Hoopes J.D., et al. Validating a custom multiplex ELISA against individual commercial immunoassays using clinical samples. BioTech 2007, 42:327-333.
7. Park Y., Park Y., Park J., Kim H.S. Evaluation of the UniCel™ DxI 800 immunoassay analyzer in measuring five tumor markers. Yonsei Med J 2012, 53:557-564.
8. Yan F., Zhou J., Lin J., Ju H., Hu X. Flow injection immunoassay for carcinoembryonic antigen combined with time-resolved fluorometric detection. J Immunol Methods 2005, 305:120-127.
9. Hou J.-Y., Liu T.-C., Lin G.F., Li Z.X., Zou L.-P., Li M., et al. Development of an immunomagnetic bead-based time-resolved fluorescence immunoassay for rapid determination of levels of carcinoembryonic antigen in human serum. Anal Chim Acta 2012, 734:93-98.
10. Chen Z.-H., Wu Y.-S., Chen M.-J., Hou J.Y., Ren Z.Q., Sun D., et al. A novel homogeneous time-resolved fluoroimmunoassay for carcinoembryonic antigen based on water-soluble quantum dots. J Fluoresc 2013, 23:649-657.
11. Xin T.-B., Wang X., Jin H., Che J.-H., Liang S.-X., Li Z.-J., et al. Microplate chemiluminescence enzyme immunoassay for the determination of carcinoembryonic antigen in human serum. Chin J Anal Chem 2008, 36:1056-1060.
12. Xue P., Zhang Z.-J., Zhang X.-M. Chemiluminescent analysis of carcinoembryonic antigen in serum samples. Chin J Anal Chem 2011, 39:95-98.
13. Qu S., Liu J., Luo J., Huang Y., Shi W., Wang B., et al. A rapid and highly sensitive portable chemiluminescent immunosensor of carcinoembryonic antigen based on immunomagnetic separation in human serum. Anal Chim Acta 2013, 766:94-99.
14. Wang S., Zhang Y., Yu J., Song X., Ge S., Yan M. Application of indium tin oxide device in gold-coated magnetic iron solid support enhanced electrochemiluminescent immunosensor for determination of carcinoma embryonic antigen. Sensors Actuators B 2012, 171-172:891-898.
15. Kricka L.J. Miniaturization of analytical systems. Clin Chem 1998, 44:2008-2014.
16. Choi Y.-E., Kwak J.-W., Park J.W. Nanotechnology for early cancer detection. Sensors 2010, 10:428-455.
17. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 2005, 5:161-171.
18. Ludwig J.A., Weinstein J.N. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 2005, 5:845-856.
19. Kingsmore S.F. Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat Rev Drug Discov 2006, 5:310-320.
20. Choi J.W., Oh K.W., Thomas J.H., Heineman W.R., Halsall H.B., Nevin J.H., et al. An integrated microfluidic biochemical detection system for protein analysis with magnetic bead-based sampling capabilities. Lab Chip 2002, 2:27-30.
21. Thomas J.H., Kim S.K., Hesketh P.J., Halsall H.B., Heineman W.R. Microbead-based electrochemical immunoassay with interdigitated array electrodes. Anal Biochem 2004, 328:113-122.
22. Zhang H., Meyerhoff M.E. Gold-coated magnetic particles for solid-phase immunoassays: enhancing immobilized antibody binding efficiency and analytical performance. Anal Chem 2006, 78:609-616.
23. Centi S., Tombelli S., Minunni M., Mascini M. Aptamer-based detection of plasma proteins by an electrochemical assay coupled to magnetic beads. Anal Chem 2007, 79:1466-1473.
24. Tsai H.Y., Hsu C.F., Chiu I.W., Bor Fu.h.C. Detection of C-reactive protein based on immunoassay using antibody-conjugated magnetic nanoparticles. Anal Chem 2007, 79:8416-8419.
25. Wang S., Zhang X., Mao X., Zeng Q., Xu H., Lin Y., et al. Electrochemical immunoassay of carcinoembryonic antigen based on a lead sulfide nanoparticle label. Nanotechnology 2008, 19:435501.
26. Franzreb M., Siemann-Herzberg M., Hobley T.J., Thomas O.R.T. Protein purification using magnetic adsorbent particles. Appl Microbiol Biotechnol 2006, 70:505-516.
27. Mani V., Chikkaveeraiah B.V., Rusling J.F. Magnetic particles in ultrasensitive biomarker protein measurements for cancer detection and monitoring. Expert Opin Med Diagn 2011, 5:381-391.
28. Xie J., Jon S. Magnetic nanoparticle-based theranostics. Theranostics 2012, 2:122-124.
29. Liu G., Wang J., Kim J., Jan M.R. Electrochemical coding for multiplexed immunoassays of proteins. Anal Chem 2004, 76:7126-7130.
30. Laurence D.J.R., Turberville C., Anderson S.G., Neville A.M. First British standard for carcinoembryonic antigen (CEA). Br J Cancer 1975, 32:295-299.
31. Martinez-Mancera F.D., Hernandez-Lopez J.L. Physical characterization and photoluminescence properties of thioglycolic acid-stabilized lead sulfide nanocrystals. Mater Chem Phys 2014, 148:1045-1054.
32. Hermanson G.T. Bioconjugate techniques 2008, 595-599. Academic Press, Amsterdam. 2nd ed.
33. de la Escosura-Muñiz A., Ambrosi A., Alegret S., Merkoçi A. Chapter 10: Electrochemical immunosensing using micro and nanoparticles. Methods in molecular biology: biosensors and biodetection 2009, 145-155. Humana Press, Totowa. 1st ed. A. Rasooly, K.E. Herold (Eds.).
34. Zumbrägel B. Electrochemistry. A laboratory textbook 2011, 55. Metrohm Ltd., Herisau.
35. Zumbrägel B. Electrochemistry. A laboratory textbook 2011, 56. Metrohm Ltd., Herisau.
36. O'Connell M.A., Belanger B.A., Haaland P.D. Calibration and assay development using the four-parameter logistic model. Chemom Intell Lab Syst 1993, 20:97-114.
37. Proll G., Tschmelak J., Gauglitz G. Fully automated biosensors for water analysis. Anal Bioanal Chem 2005, 381:61-63.
38. Dudley R.A., Edwards P., Ekins R.P., Finney D.J., McKenzie I.G.M., Raab G.M., et al. Guidelines for immunoassay data processing. Clin Chem 1985, 31:1264-1271.
39. Little J.A. Comparison of curve fitting models for ligand binding assays. Chromatographia Suppl 2004, 59:S177-S181.
40. Findlay J.W.A., Dillard R.F. Appropriate calibration curve fitting in ligand binding assays. AAPS J 2007, 9:E260-E267.
41. Inczedy J., Lengyel T., Ure A.M. The orange book. Compendium of analytical nomenclature (definitive rules 1997) 1998, Blackwell Science, Oxford. 3rd ed.
42. Stöckl D., Dewitte K., Thienpont L.M. Validity of linear regression in method comparison studies: is it limited by the statistical model or the quality of the analytical input data?. Clin Chem 1998, 44:2340-2346.
43. Deming W. Statistical adjustment of data 1943, John Wiley and Sons, New York.
44. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1:307-310.
45. Boehm M.K., Mayans M.O., Thornton J.D., Begent R.H.J., Keep P.A., Perkins S.J. Extended glycoprotein structure of the seven domains in human carcinoembryonic antigen by X-ray and neutron solution scattering and an automated curve fitting procedure: Implications for cellular adhesion. J Mol Biol 1996, 259:718-736.
46. Fragoso A., O'Sullivan C.K. Chapter 33: Electrochemical immunosensor for detection of proteic cancer markers. Biosensors and molecular technologies for cancer diagnostics 2012, 573-590. Taylor & Francis Group LLC, Boca Raton. K.E. Herold, A. Rasooly (Eds.).
47. Delgado J.C., Shulman L.N., Gudrais P.G., Fischer G.A., Ferguson D.O., Winkelman J.W., et al. Standardization of carcinoembryonic antigen testing in the setting of clinical laboratory consolidation. Lab Med 2001, 32:92-95.
48. Molina R., Jo J., Filella X., Zanon G., Pahisa J., Muñoz M., et al. c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value. Breast Cancer Res Treat 1998, 51:109-119.
49. Lumsden J. Laboratory test method validation. Revue Méd Vét 2000, 151:623-630.
50. A practical guide to internal quality control (IQC) for quantitative tests in medical laboratories (proposed guidelines) 2009, Hong Kong Association of Medical Laboratories Ltd., Hong Kong. R. Pang (Ed.).
51. Westgard J.O. Precision and accuracy: concepts and assessment by method evaluation testing. Crit Rev Clin Lab Sci 1981, 13:283-330.
52. Mujagić Z., Mujagic H., Prnjavorac B. The relationship between circulating carcinoembryonic antigen (CEA) levels and parameters of primary tumor and metastases in breast cancer patients. Med Arh 2004, 58(1):23-26.
53. Carey R.N., Garber C.C. Evaluation of methods in clinical chemistry. Clinical chemistry. Theory, analysis and correlation 1989, 290-310. CV Mosby, St. Louis. 2nd ed. L.A. Kaplan, A.J. Pesce (Eds.).
54. Passing H., Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin Biochem 1983, 21:709-720.
55. Linnet K. Evaluation of regression procedures for methods comparison studies. Clin Chem 1993, 39:424-432.
56. NCCLS Method comparison and bias estimation using patient samples; approved guideline. NCCLS document EP9-A2 2002, ISBN 1-56238-472-4. Second Edition.